Evaluation of the Outcome of COVID-19 Patients Discharged Home on Oxygen Therapy

NCT05684575 | Completed

• 1 other identifier: CHRD1921
• Study Type: interventional
• Target: 151
• Locations: 1 country
• Sites: 2

Brief Summary

The René Dubos Hospital in Pontoise has set up a home discharge system for oxygen-requiring patients in collaboration with PRADO, a health insurance organization, or private providers. This organization coordinates the care to be implemented at home based on the city/hospital link. The coordinator of this organization was also in charge of scheduling a follow-up consultation between 7 and 14 days after hospital discharge. The aim of this study is to evaluate this new organization, both in terms of its impact on patient outcomes (survival and re-hospitalization rates) and on patients' experiences and satisfaction with their care.

Conditions

COVID-19

Keywords

COVID-19; Oxygen therapy; Early return

Outcome Measures

Primary Outcomes (1)

• Description of the evolution of patients with COVID-19 who benefited from an early return home on oxygen organized by the PRADO or a private provider

  Assessment of mortality (all causes) at 30 days of hospital discharge (D30) : number of died patients

  At 30 days of hospital discharge (D30)

Secondary Outcomes (2)

• Assessment of the risk of early re-hospitalization of patients following their return home

  At 7 days from hospital discharge (D7)

• Assessment of patients' satisfaction with their care and return home

  At the end of the study, an average of 10 month

Study Arms (1)

Phone satisfaction questionnaire

OTHER

Evaluation of the outcome of Covid-19 patients discharged home on oxygen therapy

Other: Phone satisfaction questionnaire

Interventions

Phone satisfaction questionnaire OTHER

Evaluation of the outcome of Covid-19 patients discharged home on oxygen therapy

Phone satisfaction questionnaire

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients over 18 years of age
• Patients with virologically proven COVID 19 (positive Polymerase Chain Reaction or antigenic test) or based on clinical and radiological evidence
• Patients discharged from hospital or from the emergency room on oxygen between 1 and 5L at the time of discharge
• Organization of discharge by a service provider (PRADO or private)

You may not qualify if:

• Patients discharged from the intensive care unit
• Oxygen-requiring patients \> 5 Liters

Sponsors & Collaborators

• Hôpital NOVO: lead

Study Sites (2)

Polyvalent, infectious and pulmonary medicine - GHCPO Beaumont/Oise

Beaumont-sur-Oise, 95260, France

Location

Aval-emergency medicine department - Infectious diseases departement- Hospital René Dubos Pontoise

Pontoise, 95300, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Dr Celeste Lambert

  Hospital René Dubos Pontoise

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 12, 2023
• First Posted: January 13, 2023
• Study Start: February 6, 2023
• Primary Completion: April 25, 2023
• Study Completion: April 25, 2023
• Last Updated: September 19, 2024

Record last verified: 2023-05

Data Sharing

• IPD Sharing: Will not share

Locations

FR (2)